338 related articles for article (PubMed ID: 34796670)
21. Evaluation of the American Joint Committee on Cancer staging system for cutaneous squamous cell carcinoma and proposal of a new staging system.
Dinehart SM; Peterson S
Dermatol Surg; 2005 Nov; 31(11 Pt 1):1379-84. PubMed ID: 16416604
[TBL] [Abstract][Full Text] [Related]
22. Long-term clinical outcomes of patients with invasive cutaneous squamous cell carcinoma treated with Mohs micrographic surgery: A 5-year, multicenter, prospective cohort study.
Tschetter AJ; Campoli MR; Zitelli JA; Brodland DG
J Am Acad Dermatol; 2020 Jan; 82(1):139-148. PubMed ID: 31279037
[TBL] [Abstract][Full Text] [Related]
23. Sentinel Lymph Node Biopsy in High-Risk Cutaneous Squamous Cell Carcinoma: Analysis of a Large Size Retrospective Series.
Tremblay-Abel V; Poulin MA; Blouin MM; Parent F; Perron É
Dermatol Surg; 2021 Jul; 47(7):908-913. PubMed ID: 33988549
[TBL] [Abstract][Full Text] [Related]
24. Impact of Mohs Micrographic Surgery on Tumor Staging of Cutaneous Squamous Cell Carcinoma: A Comparison of the 7th and 8th Editions of the American Joint Committee on Cancer Guidelines.
Montuno MA; Brown B; Konda S; Motaparthi K
Dermatol Surg; 2018 Aug; 44(8):1057-1064. PubMed ID: 29746431
[TBL] [Abstract][Full Text] [Related]
25. Integrating gene expression profiling into NCCN high-risk cutaneous squamous cell carcinoma management recommendations: impact on patient management.
Farberg AS; Hall MA; Douglas L; Covington KR; Kurley SJ; Cook RW; Dinehart SM
Curr Med Res Opin; 2020 Aug; 36(8):1301-1307. PubMed ID: 32351136
[No Abstract] [Full Text] [Related]
26. Validation of four cutaneous squamous cell carcinoma staging systems using nationwide data.
Venables ZC; Tokez S; Hollestein LM; Mooyaart AL; van den Bos RR; Rous B; Leigh IM; Nijsten T; Wakkee M
Br J Dermatol; 2022 May; 186(5):835-842. PubMed ID: 34862598
[TBL] [Abstract][Full Text] [Related]
27. Analysis and Comparison of the 8th Edition American Joint Committee on Cancer (AJCC) Nodal Staging System in Cutaneous and Oral Squamous Cell Cancer of the Head and Neck.
Moeckelmann N; Ebrahimi A; Dirven R; Liu J; Low TH; Gupta R; Ashford B; Ch'ng S; Palme CE; Clark JR
Ann Surg Oncol; 2018 Jun; 25(6):1730-1736. PubMed ID: 29352431
[TBL] [Abstract][Full Text] [Related]
28. Metastatic Cutaneous Squamous Cell Carcinoma: The Importance of T2 Stratification and Hematologic Malignancy in Prognostication.
Stevenson ML; Kim R; Meehan SA; Pavlick AC; Carucci JA
Dermatol Surg; 2016 Aug; 42(8):932-5. PubMed ID: 27467226
[TBL] [Abstract][Full Text] [Related]
29. Integrating depth of invasion in T classification improves the prognostic performance of the American Joint Committee on Cancer primary tumor staging system for cutaneous squamous cell carcinoma of the head and neck.
Amit M; Liu C; Netto Gleber FO; Kini S; Tam S; Benov A; Aashiq M; El-Naggar AK; Moreno AC; Rosenthal DI; Glisson BS; Ferrarotto R; Wong MK; Migden MR; Li G; Khanna A; Goepfert RP; Nagarajan P; Weber RS; Myers JN; Gross ND
Eur J Cancer; 2021 Feb; 144():169-177. PubMed ID: 33352413
[TBL] [Abstract][Full Text] [Related]
30. Review of high-risk features of cutaneous squamous cell carcinoma and discrepancies between the American Joint Committee on Cancer and NCCN Clinical Practice Guidelines In Oncology.
Skulsky SL; O'Sullivan B; McArdle O; Leader M; Roche M; Conlon PJ; O'Neill JP
Head Neck; 2017 Mar; 39(3):578-594. PubMed ID: 27882625
[TBL] [Abstract][Full Text] [Related]
31. European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 2. Treatment.
Stratigos AJ; Garbe C; Dessinioti C; Lebbe C; Bataille V; Bastholt L; Dreno B; Concetta Fargnoli M; Forsea AM; Frenard C; Harwood CA; Hauschild A; Hoeller C; Kandolf-Sekulovic L; Kaufmann R; Kelleners-Smeets NWJ; Malvehy J; Del Marmol V; Middleton MR; Moreno-Ramirez D; Pellecani G; Peris K; Saiag P; van den Beuken-van Everdingen MHJ; Vieira R; Zalaudek I; Eggermont AMM; Grob JJ;
Eur J Cancer; 2020 Mar; 128():83-102. PubMed ID: 32113942
[TBL] [Abstract][Full Text] [Related]
32. Tracking the risk factors associated with high-risk cSCC: A 10-year, Two-Institution, Greek study.
Dimonitsas E; Champsas G; Kakagia D; Stavrianos S; Roussos S; Doryforou O; Neamonitou F; Soura E; Kostopoulos E; Christofidou E; Papadopulos O; Thymara I; Papadopulos NA; Stratigos A; Korkolopoulou P
J BUON; 2021; 26(3):1148-1158. PubMed ID: 34268983
[TBL] [Abstract][Full Text] [Related]
33. Understanding and use of the American Joint Committee on Cancer seventh edition guidelines for cutaneous squamous cell carcinoma: a survey of dermatologic surgeons.
LeBlanc KG; Monheit GD
Dermatol Surg; 2014 May; 40(5):505-10. PubMed ID: 24479755
[TBL] [Abstract][Full Text] [Related]
34. Staging System Performance and Clinical Outcomes for Cutaneous Squamous Cell Carcinoma of the Ear: A Single-Center Retrospective Study.
Navarrete-Dechent C; Mori S; Connolly K; Shah K; Dusza SW; Rossi AM; Lee EH; Busam KJ; Nehal KS
Dermatol Surg; 2023 Aug; 49(8):747-754. PubMed ID: 37235869
[TBL] [Abstract][Full Text] [Related]
35. An evolving paradigm for the workup and management of high-risk cutaneous squamous cell carcinoma.
O'Bryan K; Sherman W; Niedt GW; Taback B; Manolidis S; Wang A; Ratner D
J Am Acad Dermatol; 2013 Oct; 69(4):595-602.e1. PubMed ID: 23871719
[TBL] [Abstract][Full Text] [Related]
36. Time for consensus on "high-risk" - Sentinel lymph node biopsy for cutaneous squamous cell carcinoma: An international survey of skin cancer specialists and a literature update.
Baljer BC; Hill SR; Coughlan D; Vale L; Rose AM
J Plast Reconstr Aesthet Surg; 2023 Jan; 76():62-64. PubMed ID: 36513010
[TBL] [Abstract][Full Text] [Related]
37. Risk factors and timing of subsequent cutaneous squamous cell carcinoma in patients with cutaneous squamous cell carcinoma: A retrospective cohort study.
Rodriguez M; Beal BT; Manmohan M; Simmons E; Varra V; Xiong D; Eversman A; Briskin IN; Knackstedt T; Vidimos AT
J Am Acad Dermatol; 2021 Mar; 84(3):719-724. PubMed ID: 32861709
[TBL] [Abstract][Full Text] [Related]
38. Brigham and Women's Hospital tumor classification system for basal cell carcinoma identifies patients with risk of metastasis and death.
Morgan FC; Ruiz ES; Karia PS; Besaw RJ; Neel VA; Schmults CD
J Am Acad Dermatol; 2021 Sep; 85(3):582-587. PubMed ID: 33497751
[TBL] [Abstract][Full Text] [Related]
39. Detection of High-Risk Histologic Features and Tumor Upstaging of Nonmelanoma Skin Cancers on Debulk Analysis: A Quantitative Systematic Review.
Singh B; Dorelles A; Konnikov N; Nguyen BM
Dermatol Surg; 2017 Aug; 43(8):1003-1011. PubMed ID: 28654579
[TBL] [Abstract][Full Text] [Related]
40. Cutaneous Squamous Cell Carcinoma: Updates in Staging and Management.
Bander TS; Nehal KS; Lee EH
Dermatol Clin; 2019 Jul; 37(3):241-251. PubMed ID: 31084718
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
